FAM83G expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.492200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.945400E-01
Normal-vs-Stage2
6.483800E-01
Normal-vs-Stage3
3.342600E-01
Normal-vs-Stage4
9.294000E-01
Stage1-vs-Stage2
4.761800E-01
Stage1-vs-Stage3
3.954400E-01
Stage1-vs-Stage4
1.904420E-01
Stage2-vs-Stage3
1.842770E-01
Stage2-vs-Stage4
4.853000E-01
Stage3-vs-Stage4
1.525580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.728200E-01
Normal-vs-AfricanAmerican
7.794200E-01
Normal-vs-Asian
9.439400E-01
Caucasian-vs-AfricanAmerican
3.330600E-01
Caucasian-vs-Asian
5.042800E-01
AfricanAmerican-vs-Asian
6.176800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.018000E-01
Normal-vs-Female
4.988400E-01
Male-vs-Female
6.595200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.342400E-01
Normal-vs-Age(41-60Yrs)
7.571400E-01
Normal-vs-Age(61-80Yrs)
4.542400E-01
Normal-vs-Age(81-100Yrs)
5.975400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.928800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.892400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.743000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.653350E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.936600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.630000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.390600E-01
Normal-vs-Daily Drinker
1.766440E-01
Normal-vs-Weekly Drinker
5.795200E-01
Normal-vs-Occasional Drinker
6.001800E-01
Normal-vs-Social Drinker
5.089000E-01
Non Drinker-vs-Daily Drinker
4.936400E-02
Non Drinker-vs-Weekly Drinker
5.918200E-01
Non Drinker-vs-Occasional Drinker
7.371000E-01
Non Drinker-vs-Social Drinker
4.821200E-01
Daily Drinker-vs-Weekly Drinker
2.544800E-01
Daily Drinker-vs-Occasional Drinker
1.034960E-01
Daily Drinker-vs-Social Drinker
2.932000E-01
Weekly Drinker-vs-Occasional Drinker
8.053000E-01
Weekly Drinker-vs-Social Drinker
9.023600E-01
Occasional Drinker-vs-Social Drinker
6.863600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.283420E-01
Normal-vs-Grade 2
3.218100E-02
Normal-vs-Grade 3
1.035750E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.982400E-01
Grade 1-vs-Grade 3
7.717500E-02
Grade 1-vs-Grade 4
1.283420E-01
Grade 2-vs-Grade 3
2.548200E-01
Grade 2-vs-Grade 4
3.218100E-02
Grade 3-vs-Grade 4
1.035750E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.587400E-01
Normal-vs-NonDiabetic
5.245600E-01
Diabetic-vs-NonDiabetic
2.927000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.247600E-01
Normal-vs-NoPancreatitis
4.326000E-01
Pancreatitis-vs-NoPancreatitis
3.978200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.721000E-01
Normal-vs-N1
6.184800E-01
N0-vs-N1
3.378400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.612800E-01
Normal-vs-TP53-NonMutant
8.217800E-01
TP53-Mutant-vs-TP53-NonMutant
5.247000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
